Identifying how metabolic changes in mantle cell lymphoma respond to a specific cancer treatment.
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition
This study is looking at new, gentle ways to see how well treatments for mantle cell lymphoma are working by checking changes in the tumor's metabolism, which could help doctors make quicker decisions about your care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10792594 on NIH RePORTER |
What this research studies
This research focuses on developing noninvasive methods to detect how mantle cell lymphoma responds to treatment with Bruton Tyrosine Kinase inhibitors. By monitoring metabolic changes in tumors, the study aims to identify early signs of treatment effectiveness or resistance, which can be more reliable than traditional imaging techniques. The approach involves using advanced imaging to track key metabolic pathways affected by the treatment, allowing for timely adjustments in therapy. This could lead to better management of the disease and improved outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with mantle cell lymphoma who are undergoing treatment with Bruton Tyrosine Kinase inhibitors.
Not a fit: Patients with other types of cancers or those not receiving Bruton Tyrosine Kinase inhibitors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enable earlier detection of treatment responses in mantle cell lymphoma, leading to more effective and personalized treatment strategies.
How similar studies have performed: Other research has shown promise in using metabolic monitoring for cancer treatment responses, suggesting that this approach could be effective.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Nath, Kavindra — University of Pennsylvania
- Study coordinator: Nath, Kavindra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.